Long Term Analysis of Microbiological Isolates and Antibiotic Susceptibilities in Acute-onset Postoperative Endophthalmitis: a UK Multicentre Study

Overview

Journal Eye (Lond)

Specialty Ophthalmology

Date 2025 Feb 12

PMID 39939392

Authors

Boon Lin Teh

Ariel Yuhan Ong

Ankur Mehta

Vy Hoang

Chris Settle

Andrew J Lotery

Peter Charbel Issa

Jonathan Smith

David H Steel

Affiliations

Soon will be listed here.

Abstract

Objectives: To review the trend of microbial isolates for postoperative endophthalmitis (POE) in the United Kingdom (UK) and determine the sensitivity to current empirical intravitreal antibiotic treatment.

Methods: We conducted a long term multicentre consecutive case review of POE across 3 geographically distant tertiary eye centres in the UK: Sunderland Eye Infirmary (2000-2022), Oxford Eye Hospital (2016-2022), and Southampton General Hospital (2016-2022). Data on the microbial samples taken and results including sensitivities to antibiotics agents given were collected. Poisson regression was used to analyse microbial trends and outcomes were considered statistically significant at a level of p < 0.05.

Results: 179 consecutive eyes of 177 patients with POE met our inclusion criteria. The most common primary procedure was phacoemulsification and IOL insertion followed by intravitreal injections. 104 (58.1%) were culture positive and most were Gram-positive bacteria (85, 81.7%). The microbial trend consistently showed Staphylococcus epidermidis and unspecified coagulase-negative Staphylococci to be the most prevalent pathogens. Poisson regression showed no statistically significant change in any of the bacterial isolates over our study period. Antibiotic sensitivity data was available for 74% of the culture positive samples (77/104). All Gram-positive bacteria (68/68, 100%) and most (8/9, 88.9%) Gram-negative bacteria were sensitive to the empirical antibiotics (Vancomycin and Ceftazidime/Amikacin) given at presentation.

Conclusions: Most of the bacterial isolates causing POE in the UK are Gram-positive bacteria, and the trend has remained stable over more than two decades. Current empirical treatment with intravitreal Vancomycin and Ceftazidime/Amikacin provides effective broad coverage for the vast majority of cases.

References

Behndig A, Cochener B, Guell J, Kodjikian L, Mencucci R, Nuijts R . Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013; 39(9):1421-31. DOI: 10.1016/j.jcrs.2013.06.014. View

Sadaka A, Durand M, Gilmore M . Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog Retin Eye Res. 2012; 31(4):316-31. PMC: 3361607. DOI: 10.1016/j.preteyeres.2012.03.004. View

Nentwich M, Ta C, Kreutzer T, Li B, Schwarzbach F, Yactayo-Miranda Y . Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution. J Cataract Refract Surg. 2014; 41(1):58-66. DOI: 10.1016/j.jcrs.2014.04.040. View

Asencio M, Huertas M, Carranza R, Tenias J, Celis J, Gonzalez-Del Valle F . A case-control study of post-operative endophthalmitis diagnosed at a Spanish hospital over a 13-year-period. Epidemiol Infect. 2014; 143(1):178-83. PMC: 9206787. DOI: 10.1017/S095026881400034X. View

Daien V, Papinaud L, Gillies M, Domerg C, Nagot N, Lacombe S . Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. JAMA Ophthalmol. 2016; 134(7):810-6. DOI: 10.1001/jamaophthalmol.2016.1351. View

Chopra R, Preston G, Keenan T, Mulholland P, Patel P, Balaskas K . Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye (Lond). 2021; 36(7):1373-1378. PMC: 8227364. DOI: 10.1038/s41433-021-01646-3. View

Keenan T, Wotton C, Goldacre M . Trends over time and geographical variation in rates of intravitreal injections in England. Br J Ophthalmol. 2011; 96(3):413-8. DOI: 10.1136/bjophthalmol-2011-300338. View

Malmin A, Syre H, Ushakova A, Utheim T, Forsaa V . Twenty years of endophthalmitis: Incidence, aetiology and clinical outcome. Acta Ophthalmol. 2020; 99(1):e62-e69. DOI: 10.1111/aos.14511. View

Ong A, Rigaudy A, Toufeeq S, Robins J, Shalchi Z, Bindra M . Intravitreal injections as a leading cause of acute postoperative endophthalmitis-a regional survey in England. Eye (Lond). 2021; 37(1):163-169. PMC: 9829718. DOI: 10.1038/s41433-021-01886-3. View

10.

VanderBeek B, Chen Y, Tomaiuolo M, Deaner J, Syed Z, Acharya B . Endophthalmitis Rates and Types of Treatments After Intraocular Procedures. JAMA Ophthalmol. 2024; 142(9):827-834. PMC: 11295066. DOI: 10.1001/jamaophthalmol.2024.2749. View

11.

Relhan N, Pathengay A, Schwartz S, Flynn Jr H . Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. Retina. 2017; 37(5):811-818. PMC: 5397345. DOI: 10.1097/IAE.0000000000001603. View

12.

Liu C, Ding B, Ji J, Wang Z, Chen H, Cao W . Microbial Spectrum and Resistance Patterns in Ocular Infections: A 15-Year Review in East China. Infect Drug Resist. 2021; 14:2165-2171. PMC: 8203601. DOI: 10.2147/IDR.S314647. View

13.

Day A, Donachie P, Sparrow J, Johnston R . The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015; 29(4):552-60. PMC: 4816350. DOI: 10.1038/eye.2015.3. View

14.

eClinicalMedicine . Antimicrobial resistance: a top ten global public health threat. EClinicalMedicine. 2021; 41:101221. PMC: 8633964. DOI: 10.1016/j.eclinm.2021.101221. View

15.

Velez-Montoya R, Monroy-Esquivel L, Ortiz-Guevara R, Quiroz-Mercado H, Fromow-Guerra J . ALTERNATIVE INTRAVITREAL ANTIBIOTICS: A Systematic Review for Consideration in Recalcitrant or Resistant Endophthalmitis. Retina. 2023; 43(9):1433-1447. DOI: 10.1097/IAE.0000000000003773. View

16.

Chen K, Sun M, Hou C, Chen H, Chen Y, Wang N . Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin. Sci Rep. 2021; 11(1):15878. PMC: 8342408. DOI: 10.1038/s41598-021-95458-w. View

17.

Clarke B, Williamson T, Gini G, Gupta B . Management of bacterial postoperative endophthalmitis and the role of vitrectomy. Surv Ophthalmol. 2018; 63(5):677-693. DOI: 10.1016/j.survophthal.2018.02.003. View

18.

Seal D, Reischl U, Behr A, Ferrer C, Alio J, Koerner R . Laboratory diagnosis of endophthalmitis: comparison of microbiology and molecular methods in the European Society of Cataract & Refractive Surgeons multicenter study and susceptibility testing. J Cataract Refract Surg. 2008; 34(9):1439-50. DOI: 10.1016/j.jcrs.2008.05.043. View

19.

Lalitha P, Sengupta S, Ravindran R, Sharma S, Joseph J, Ambiya V . A literature review and update on the incidence and microbiology spectrum of postcataract surgery endophthalmitis over past two decades in India. Indian J Ophthalmol. 2017; 65(8):673-677. PMC: 5598176. DOI: 10.4103/ijo.IJO_509_17. View

20.

Bhattacharjee H, Bhattacharjee K, Gogoi K, Singh M, Singla B, Yadav A . Microbial profile of the vitreous aspirates in culture proven exogenous endophthalmitis: A 10-year retrospective study. Indian J Med Microbiol. 2016; 34(2):153-8. DOI: 10.4103/0255-0857.180280. View